Veterinary medicine is often derived from human medicine, yet in spite of significant advancements to treat human cancers in recent years, only a handful of breakthrough veterinary products have ever been developed for animal cancers.
VetDC is a cancer-focused veterinary biopharmaceutical company, founded on the principle that companion animals deserve greater access to novel, innovative medical treatments.
Cancer is the leading killer of adult pets today, and unfortunately, there are no cures. In spite of a trend to treat cancer as a chronic disease, there is a surprising lack of effective and well-tolerated cancer therapies available to the veterinary community today. VetDC intends to change that paradigm. Working closely with Colorado State University's world-renowned Flint Animal Cancer Center, VetDC is developing several novel, targeted anticancer therapies specifically for the benefit of companion animals.